AU2001281499B2 - Methods and reagents for regulation of cellular responses in biological systems - Google Patents

Methods and reagents for regulation of cellular responses in biological systems Download PDF

Info

Publication number
AU2001281499B2
AU2001281499B2 AU2001281499A AU2001281499A AU2001281499B2 AU 2001281499 B2 AU2001281499 B2 AU 2001281499B2 AU 2001281499 A AU2001281499 A AU 2001281499A AU 2001281499 A AU2001281499 A AU 2001281499A AU 2001281499 B2 AU2001281499 B2 AU 2001281499B2
Authority
AU
Australia
Prior art keywords
cell
multivalent
ligand
sre
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001281499A
Other languages
English (en)
Other versions
AU2001281499A1 (en
Inventor
Jason E. Gestwicki
Laura L Kiessling
Laura E. Strong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of AU2001281499A1 publication Critical patent/AU2001281499A1/en
Application granted granted Critical
Publication of AU2001281499B2 publication Critical patent/AU2001281499B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178—Lectin superfamily, e.g. selectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nanotechnology (AREA)
  • Cell Biology (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Composite Materials (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
AU2001281499A 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems Ceased AU2001281499B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19101400P 2000-03-21 2000-03-21
US60/191,014 2000-03-21
PCT/US2001/009174 WO2001071309A2 (en) 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems

Publications (2)

Publication Number Publication Date
AU2001281499A1 AU2001281499A1 (en) 2001-12-13
AU2001281499B2 true AU2001281499B2 (en) 2007-01-04

Family

ID=22703769

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001281499A Ceased AU2001281499B2 (en) 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems
AU8149901A Pending AU8149901A (en) 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU8149901A Pending AU8149901A (en) 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems

Country Status (6)

Country Link
US (2) US20030125262A1 (https=)
EP (1) EP1334118A4 (https=)
JP (1) JP2004512258A (https=)
AU (2) AU2001281499B2 (https=)
CA (1) CA2403669A1 (https=)
WO (1) WO2001071309A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248801A1 (en) * 2000-03-21 2004-12-09 Kiessling Laura L. Methods and reagents for regulation of cellular responses in biological systems
JP2004512258A (ja) * 2000-03-21 2004-04-22 ウィスコンシン　アルムニ　リサーチ　ファンデイション 生物系における細胞応答の調節のための方法および試薬
WO2004100997A2 (en) 2003-05-12 2004-11-25 Affymax, Inc. Spacer moiety for poly(ethylene glycol) -modified peptides
JP2007530440A (ja) * 2003-05-12 2007-11-01 アフィーマックス・インコーポレイテッド 新規ポリ（エチレングリコール）修飾化合物およびその用途
SI1625156T1 (sl) * 2003-05-12 2013-02-28 Affymax, Inc. Peptidi, ki se veĹľejo k eritropoetinskemu receptorju
JP4266028B2 (ja) 2003-05-12 2009-05-20 アフィーマックス・インコーポレイテッド エリスロポエチン受容体に結合する新規ペプチド
WO2006062685A2 (en) * 2004-11-11 2006-06-15 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
EA200700990A1 (ru) * 2004-11-11 2008-04-28 Афимакс, Инк. Новые пептиды, которые связывают рецептор эритропоэтина
GB0426822D0 (en) * 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
GB0426823D0 (en) * 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7919461B2 (en) 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
JP4742339B2 (ja) * 2005-06-14 2011-08-10 独立行政法人産業技術総合研究所 シアル酸含有３糖化合物、それを用いるサーズウイルスまたはサーズスパイク蛋白質の検出
EP2015784A4 (en) * 2006-05-03 2012-12-26 Wisconsin Alumni Res Found USING RING OPENING METATHESISPOLYMERIZATION SYNTHETIZED MAGNETIC RESONANCE GRAIN
WO2008116293A1 (en) * 2007-03-23 2008-10-02 The Governors Of The University Of Alberta Multivalent heterobifunctional polymers and methods of their use
US9029332B2 (en) 2010-12-15 2015-05-12 The Research Foundation For The State University Of New York Cross-linked peptides and proteins, methods of making same, and uses thereof
US20140350370A1 (en) * 2013-04-08 2014-11-27 The Texas A&M University System Glucose sensing assay
WO2018200951A1 (en) * 2017-04-28 2018-11-01 Tran David T Multi-targeted multi-valent ligand-drug particles for the treatment and prevention of diseases and conditions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587442A (en) * 1994-12-23 1996-12-24 Kiessling; Laura L. Polyglycomers
AU5835100A (en) * 1999-06-29 2001-01-31 Peter Szego Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427660A (en) * 1982-03-03 1984-01-24 Research Corporation Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections
US4883851A (en) * 1988-07-25 1989-11-28 California Institute Of Technology Ring opening metathesis polymerization of strained cyclic ethers
US5100972A (en) * 1990-07-16 1992-03-31 General Electric Company Cycloalkene terminated polyarylene ether
US5641622A (en) * 1990-09-13 1997-06-24 Baxter International Inc. Continuous centrifugation process for the separation of biological components from heterogeneous cell populations
US5312940A (en) * 1992-04-03 1994-05-17 California Institute Of Technology Ruthenium and osmium metal carbene complexes for olefin metathesis polymerization
US5710298A (en) * 1992-04-03 1998-01-20 California Institute Of Technology Method of preparing ruthenium and osmium carbene complexes
JP3067031B2 (ja) * 1992-04-03 2000-07-17 カリフォルニア インスティチュート オブ テクノロジー オレフィンメタセシス重合方法
US5599912A (en) * 1993-09-10 1997-02-04 Coretech, Inc. Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances
US5831108A (en) * 1995-08-03 1998-11-03 California Institute Of Technology High metathesis activity ruthenium and osmium metal carbene complexes
US6060570A (en) * 1996-08-12 2000-05-09 Bp Amoco Corporation Process for preparation of addition products of difunctional telechelic polyolefins from cyclic olefins by olefin metathesis reaction
US6080826A (en) * 1997-01-06 2000-06-27 California Institute Of Technology Template-directed ring-closing metathesis and ring-opening metathesis polymerization of functionalized dienes
US5889128A (en) * 1997-04-11 1999-03-30 Massachusetts Institute Of Technology Living olefin polymerization processes
DE19742980A1 (de) * 1997-09-29 1999-04-01 Espe Dental Ag Dentalmassen auf der Basis von ROMP-Oligomeren oder -Polymeren
US6121236A (en) * 1998-03-24 2000-09-19 The Children's Medical Center Corporation Multivalent ligands which modulate angiogenesis
US6437119B1 (en) * 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
US6280527B1 (en) * 1998-06-12 2001-08-28 International Business Machines Corporation Aqueous quaternary ammonium hydroxide as a screening mask cleaner
US6271315B1 (en) * 1999-06-17 2001-08-07 Wisconsin Alumni Research Foundation Methods for making multivalent arrays
US6291616B1 (en) * 1999-06-17 2001-09-18 Wisconsin Alumni Research Foundation Methods and reagents for capping ruthenium or osmium carbene-catalyzed ROMP products
GB9916235D0 (en) * 1999-07-09 1999-09-15 Univ Durham Process for polymerisation of olefins and novel polymerisable olefins
US20040248801A1 (en) * 2000-03-21 2004-12-09 Kiessling Laura L. Methods and reagents for regulation of cellular responses in biological systems
JP2004512258A (ja) * 2000-03-21 2004-04-22 ウィスコンシン　アルムニ　リサーチ　ファンデイション 生物系における細胞応答の調節のための方法および試薬
EP2015784A4 (en) * 2006-05-03 2012-12-26 Wisconsin Alumni Res Found USING RING OPENING METATHESISPOLYMERIZATION SYNTHETIZED MAGNETIC RESONANCE GRAIN

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587442A (en) * 1994-12-23 1996-12-24 Kiessling; Laura L. Polyglycomers
AU5835100A (en) * 1999-06-29 2001-01-31 Peter Szego Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Andrade-Gordon et.al. (1999) Proc Nat Acad Sci USA, 96(22):12257-62 *
Gordon et.al. (2000) Chemistry & Biology, 7(1):9-16 *
Mammen et.al. (1998) Agnew Chem Int Ed, 37:2754-2794. *
Pohl & Kiessling (1999) Synthesis, SI:1515-1519 *
Sanders et.al. (1999) J Biol Chem, 274(9):5271-5278 *

Also Published As

Publication number Publication date
JP2004512258A (ja) 2004-04-22
EP1334118A4 (en) 2005-10-05
CA2403669A1 (en) 2001-09-27
US20030125262A1 (en) 2003-07-03
WO2001071309A2 (en) 2001-09-27
AU8149901A (en) 2001-10-03
EP1334118A2 (en) 2003-08-13
WO2001071309A3 (en) 2003-05-15
US20070270351A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
US20070270351A1 (en) Methods and Reagents for Regulation of Cellular Responses in Biological Systems
US20100104585A1 (en) Methods and Reagents for Regulation of Cellular Responses in Biological Systems
AU2001281499A1 (en) Methods and reagents for regulation of cellular responses in biological systems
Gao et al. Exploring and controlling the polymorphism in supramolecular assemblies of carbohydrates and proteins
Jain et al. Contribution of Porphyromonas gingivalis lipopolysachharide to periodontitis
Kiessling et al. Synthetic multivalent ligands in the exploration of cell-surface interactions
AU2015305108B2 (en) Methods and reagents for prevention and/or treatment of infection
Meléndez et al. Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
US20100190690A1 (en) Biomimetic particles and films for pathogen capture and other uses
AU7106998A (en) Molecules presenting a multitude of active moieties
CN116507369A (zh) 唾液酸配体修饰疗法
Kiessling et al. Multivalency in biological systems
WO1998047002A2 (en) Polyvalent presenter combinatorial libraries and their uses
Makowska et al. Impact of lipidation site on the activity of α-helical antimicrobial peptides
Cawley et al. Detection and characterization of vesicular gangliosides binding to myelin-associated glycoprotein on supported lipid bilayers
US5962423A (en) Treatment of bacterial dysentery
JP2005526692A (ja) 炭水化物ハプテンの免疫原共役体および凝集タンパク質キャリヤ
WO1998026662A1 (en) Compounds and methods for treating and preventing bacterial and viral disease
WO1998026662A9 (en) Compounds and methods for treating and preventing bacterial and viral disease
JP2008501725A (ja) グリカンに特異的な受容体として機能するインテグリンを介したグリコシルホスファチジルイノシトールグリカンシグナル伝達
EP4681724A1 (en) Protein for inhibiting excessive inflammatory response and use thereof
Roy Designing novel multivalent glycotools for biochemical investigations related to sialic acid
Wu et al. Glycosylphosphatidylinositols are potential targets for the development of novel inhibitors for aerolysin‐type of pore‐forming bacterial toxins
WO2008154603A1 (en) Biomimetic particles and films for pathogen capture and other uses
Anderluh DC-SIGN antagonists–A paradigm of C-type lectin binding inhibition

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired